CCEL Insider Trading

Insider Ownership Percentage: 36.86%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Cryo-Cell International Insider Trading History Chart

This chart shows the insider buying and selling history at Cryo-Cell International by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cryo-Cell International Share Price & Price History

Current Price: $7.83
Price Change: Price Decrease of -0.07 (-0.89%)
As of 12/20/2024 05:32 PM ET

This chart shows the closing price history over time for CCEL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cryo-Cell International Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2022David PortnoyCEOBuy516$4.90$2,528.40230,087View SEC Filing Icon  
11/14/2022David PortnoyCEOBuy10,000$4.80$48,000.00220,080View SEC Filing Icon  
11/10/2022David PortnoyCEOBuy3,850$4.90$18,865.00117,012View SEC Filing Icon  
11/8/2022David PortnoyCEOBuy20,000$4.89$97,800.00204,080View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cryo-Cell International (NYSEAMERICAN:CCEL)

10.44% of Cryo-Cell International stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CCEL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cryo-Cell International Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC39,860$0.25M0.0%+68.5%0.495%Search for SEC Filing on Google Icon
4/9/2024Massmutual Trust Co. FSB ADV111,035$0.83M0.0%-2.8%1.339%Search for SEC Filing on Google Icon
4/8/2024Rowlandmiller & PARTNERS.ADV14,433$0.11M0.0%N/A0.174%Search for SEC Filing on Google Icon
1/3/2024Massmutual Trust Co. FSB ADV114,213$0.66M0.0%-8.0%1.378%Search for SEC Filing on Google Icon
2/9/2023Hamilton Lane Advisors LLC409,734$1.73M0.6%N/A4.810%Search for SEC Filing on Google Icon
8/15/2022Iszo Capital Management LP353,210$2.08M3.3%-1.1%4.211%Search for SEC Filing on Google Icon
7/7/2022Massmutual Trust Co. FSB ADV124,135$0.73M0.0%+63.3%1.467%Search for SEC Filing on Google Icon
5/16/2022Iszo Capital Management LP357,107$2.73M3.2%-26.1%4.221%Search for SEC Filing on Google Icon
2/15/2022SFI Advisors LLC165,300$1.57M1.4%N/A1.938%Search for SEC Filing on Google Icon
2/14/2022Rowland & Co. Investment Counsel ADV11,000$0.13M0.0%N/A0.129%Search for SEC Filing on Google Icon
11/15/2021HighTower Advisors LLC12,761$0.16M0.0%N/A0.150%Search for SEC Filing on Google Icon
11/15/2021Maryland Capital Management19,563$0.24M0.0%N/A0.229%Search for SEC Filing on Google Icon
11/3/2021Seizert Capital Partners LLC43,483$0.53M0.0%-4.6%0.510%Search for SEC Filing on Google Icon
8/5/2021Legato Capital Management LLC23,189$0.21M0.0%N/A0.291%Search for SEC Filing on Google Icon
8/5/2021Seizert Capital Partners LLC45,594$0.41M0.0%+104.1%0.571%Search for SEC Filing on Google Icon
5/5/2021Seizert Capital Partners LLC22,339$0.20M0.0%N/A0.295%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cryo-Cell International logo
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Read More on Cryo-Cell International

Today's Range

Now: $7.83
Low: $7.68
High: $7.85

50 Day Range

MA: N/A

52 Week Range

Now: $7.83
Low: $4.47
High: $9.50

Volume

5,450 shs

Average Volume

11,103 shs

Market Capitalization

$63.11 million

P/E Ratio

N/A

Dividend Yield

12.21%

Beta

0.49

Who are the major institutional investors of Cryo-Cell International?

Cryo-Cell International's top institutional shareholders include:
  1. Geode Capital Management LLC — 0.49%
Learn More about top institutional investors of Cryo-Cell International stock.

Which major investors are buying Cryo-Cell International stock?

In the previous quarter, CCEL stock was purchased by institutional investors including:
  1. Geode Capital Management LLC